Supportive therapy and complementary medicine in renal cell carcinoma von Johannsen, M., Stoll, C., Raida, M., van Oorschot, B., Flörcken, A.

Volltext

Thrombus or tumor? A case report of a rare sarcoma entity: intimal sarcoma of the pulmonary arteries von Dörr, A., Flörcken, A., Bullinger, L., Capper, D., Deimling, A. Von, Kaul, D., Märdian, S., Starck, C., Horst, D., Dragomir, M.P., Schäfer, F.M., Jarosch, A.

Volltext

Impact of a specialised palliative care intervention in patients with advanced soft tissue sarcoma - a single-centre retrospective analysis von Brandes, F., Striefler, J. K., Doerr, A., Schmiester, M., Maerdian, S., Koulaxouzidis, G., Kaul, D., Behzadi, A., Thuss-Patience, P., Ahn, J., Pelzer, U., Bullinger, L., Floercken, A.

Volltext

Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy von Johannsen, M., Staehler, M., Ohlmann, C.-H., Flörcken, A., Schmittel, A., Otto, T., Bex, A., Hein, P., Miller, K., Weikert, S., Grünwald, V.

Volltext

Allogeneic gene-modified tumor cells (RCC-26 IL-7 CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study von Westermann, J, Flörcken, A, Willimsky, G, van Lessen, A, Kopp, J, Takvorian, A, Jöhrens, K, Lukowsky, A, Schönemann, C, Sawitzki, B, Pohla, H, Frank, R, Dörken, B, Schendel, D J, Blankenstein, T, Pezzutto, A

Volltext

Introduction of a ketogenic diet in young infants von Klepper, J., Leiendecker, B., Bredahl, R., Athanassopoulos, S., Heinen, F., Gertsen, E., Flörcken, A., Metz, A., Voit, T.

Volltext

1553TiP A phase III study comparing the efficacy of the combination of doxorubicin and the tumor-targeting human antibody-cytokine fusion protein L19TNF to doxorubicin alone as fir... von Schliemann, C., Pink, D., Flörcken, A., Ahrens, M., Egerer, G., Götze, K., Palmerini, E., Stacchiotti, S., Grignani, G., Rutkowski, P., Ullrich, R., Strapatsas, J., Hemmerle, T., Neri, D., Kessler, T.

Volltext

679P Final results on efficacy and patient reported outcomes (PRO) of a randomized phase II trial investigating nivolumab switch-maintenance after TKI induction in metastatic clear... von Darr, C., Zschäbitz, S., Ivanyi, P., Wirth, M., Staib, P., Schostak, M., Müller, L., Metz, M., Bergmann, L., Steiner, T., Lorch, A., Schütt, P., Rafiyan, M-R., Hellmis, E., Hinke, A., Mänz, M., Meiler, J., Kretz, T., Flörcken, A., Grünwald, V.

Volltext

A phase II trial of TKI induction followed by a randomized comparison between nivolumab or TKI continuation in renal cell carcinoma (NIVOSWITCH) von Grünwald, V., Grüllich, C., Ivanyi, P., Wirth, M., Staib, P., Schostak, M., Dargatz, P., Müller, L., Metz, M., Bergmann, L., Welslau, M.K., Schütt, P., Rafiyan, M.-R., Hellmis, E., Hinke, A., Meiler, J., Kretz, T., Loidl, W.C., Flörcken, A., Steiner, T.

Volltext

959P - A phase II trial of TKI induction followed by a randomized comparison between nivolumab or TKI continuation in renal cell carcinoma (NIVOSWITCH) von Grünwald, V., Grüllich, C., Ivanyi, P., Wirth, M., Staib, P., Schostak, M., Dargatz, P., Müller, L., Metz, M., Bergmann, L., Welslau, M.K., Schütt, P., Rafiyan, M.-R., Hellmis, E., Hinke, A., Meiler, J., Kretz, T., Loidl, W.C., Flörcken, A., Steiner, T.

Volltext

Community-driven development of a modified progression-free survival ratio for precision oncology von Mock, Andreas, Heilig, Christoph E, Kreutzfeldt, Simon, Huebschmann, Daniel, Heining, Christoph, Schröck, Evelin, Brors, Benedikt, Stenzinger, Albrecht, Jäger, Dirk, Schlenk, Richard, Glimm, Hanno, Fröhling, Stefan, Horak, Peter

Volltext

959PA phase II trial of TKI induction followed by a randomized comparison between nivolumab or TKI continuation in renal cell carcinoma (NIVOSWITCH) von Grünwald, V, Grüllich, C, Ivanyi, P, Wirth, M, Staib, P, Schostak, M, Dargatz, P, Müller, L, Metz, M, Bergmann, L, Welslau, M K, Schütt, P, Rafiyan, M-R, Hellmis, E, Hinke, A, Meiler, J, Kretz, T, Loidl, W C, Flörcken, A, Steiner, T

Volltext

Sarcoma Patients Admitted to the Intensive Care Unit (ICU): Predictive Relevance of Common Sepsis and Performance Parameters von Striefler, Jana K, Binder, Phung T, Brandes, Franziska, Rau, Daniel, Wittenberg, Silvan, Kaul, David, Roohani, Siyer, Jarosch, Armin, Schäfer, Frederik M, Öllinger, Robert, Märdian, Sven, Bullinger, Lars, Eckardt, Kai-Uwe, Kruse, Jan, Flörcken, Anne

Volltext

Autosomal dominant transmission of GLUT1 deficiency von KLEPPER, Jörg, WILLEMSEN, Michèl, VERRIPS, Aad, GUERTSEN, Elena, HERRMANN, Ralf, KUTZICK, Christian, FLÖRCKEN, Anne, VOIT, Thomas

Volltext

Efficacy and safety of sunitinib in patients with metastatic renal cell carcinoma on hemodialysis von Casper, J., Goebel, D., Gruenwald, V., Flörcken, A., Mueller, D., Toussaint, K., Metzner, B.

Volltext

Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro von KLEPPER, Jörg, FLÖREKEN, Anne, FISCHBARG, Jorge, VOIT, Thomas

Volltext

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes von Ostendorf, Benjamin N, Flenner, Eva, Flörcken, Anne, Westermann, Jörg

Volltext

A retrospective case–control study for the comparison of 5-year survival rates: the role of adjuvant and neoadjuvant chemotherapy in craniofacial bone sarcoma in adults von Hofmann, Elena, Preissner, Saskia, Hertel, Moritz, Preissner, Robert, Rendenbach, Carsten, Flörcken, Anne, Heiland, Max

Volltext

Centralized and Interdisciplinary Therapy Management in the Treatment of Sarcomas von Strönisch, Annika, Märdian, Sven, Flörcken, Anne

Volltext

An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma von Grünwald, Viktor, Eberhardt, Berit, Bex, Axel, Flörcken, Anne, Gauler, Thomas, Derlin, Thorsten, Panzica, Martin, Dürr, Hans Roland, Grötz, Knut Achim, Giles, Rachel H., von Falck, Christian, Graser, Anno, Muacevic, Alexander, Staehler, Michael

Volltext